These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 12491232)

  • 1. Latent tuberculosis: models, mechanisms, and novel prospects for eradication.
    Riska PF; Carleton S
    Semin Pediatr Infect Dis; 2002 Oct; 13(4):263-72. PubMed ID: 12491232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Latent tuberculosis infection].
    Neurenberger E; Bishai WR; Groose JH
    Probl Tuberk Bolezn Legk; 2005; (2):45-51. PubMed ID: 15881971
    [No Abstract]   [Full Text] [Related]  

  • 6. Therapeutic effect of DNA vaccines combined with chemotherapy in a latent infection model after aerosol infection of mice with Mycobacterium tuberculosis.
    Ha SJ; Jeon BY; Kim SC; Kim DJ; Song MK; Sung YC; Cho SN
    Gene Ther; 2003 Sep; 10(18):1592-9. PubMed ID: 12907951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A coordinated strategy for evaluating new vaccines for human and animal tuberculosis.
    McMurray DN
    Tuberculosis (Edinb); 2001; 81(1-2):141-6. PubMed ID: 11463235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Latent tuberculosis infection: recommendations for preventive therapy in adults in Germany].
    Schaberg T; Hauer B; Haas WH; Hohlfeld J; Kropp R; Loddenkemper R; Loytved G; Magdorf K; Rieder HL; Sagebiel D
    Pneumologie; 2004 Apr; 58(4):255-70. PubMed ID: 15098162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in diagnosis and therapy of childhood tuberculosis.
    Woods CR
    Paediatr Respir Rev; 2006; 7 Suppl 1():S130-1. PubMed ID: 16798538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is the development of a new tuberculosis vaccine possible?
    Kaufmann SH
    Nat Med; 2000 Sep; 6(9):955-60. PubMed ID: 10973302
    [No Abstract]   [Full Text] [Related]  

  • 11. Animal models of tuberculosis.
    Gupta UD; Katoch VM
    Tuberculosis (Edinb); 2005; 85(5-6):277-93. PubMed ID: 16249122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current issues in global tuberculosis control.
    Frothingham R; Stout JE; Hamilton CD
    Int J Infect Dis; 2005 Nov; 9(6):297-311. PubMed ID: 16183319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccine approaches to prevent tuberculosis.
    Wiker HG; Mustafa T; Målen H; Riise AM
    Scand J Immunol; 2006 Sep; 64(3):243-50. PubMed ID: 16918693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evolution of IGRA researches].
    Ariga H; Harada N
    Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The potential of azole antifungals against latent/persistent tuberculosis.
    Ahmad Z; Sharma S; Khuller GK
    FEMS Microbiol Lett; 2006 May; 258(2):200-3. PubMed ID: 16640573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genes and regulatory networks involved in persistence of Mycobacterium tuberculosis.
    Wang X; Wang H; Xie J
    Sci China Life Sci; 2011 Apr; 54(4):300-10. PubMed ID: 21267668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of Mycobacterium tuberculosis with the host: consequences for vaccine development.
    Dietrich J; Doherty TM
    APMIS; 2009 May; 117(5-6):440-57. PubMed ID: 19400867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overcoming the global crisis: "yes, we can", but also for TB ... ?
    Ottenhoff TH
    Eur J Immunol; 2009 Aug; 39(8):2014-20. PubMed ID: 19672895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel recombinant BCG expressing perfringolysin O and the over-expression of key immunodominant antigens; pre-clinical characterization, safety and protection against challenge with Mycobacterium tuberculosis.
    Sun R; Skeiky YA; Izzo A; Dheenadhayalan V; Imam Z; Penn E; Stagliano K; Haddock S; Mueller S; Fulkerson J; Scanga C; Grover A; Derrick SC; Morris S; Hone DM; Horwitz MA; Kaufmann SH; Sadoff JC
    Vaccine; 2009 Jul; 27(33):4412-23. PubMed ID: 19500523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of iron loading on the activity of isoniazid or ethambutol in the treatment of murine tuberculosis.
    Lounis N; Maslo C; Truffot-Pernot C; Grosset J; Boelaert RJ
    Int J Tuberc Lung Dis; 2003 Jun; 7(6):575-9. PubMed ID: 12797701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.